AstraZeneca | Investor Event Presentation Deck | 52 slides · page 21 of 52
The slide uses a three-column layout to explain the product, the strategy, and the clinical trial pipeline.
Conference presentation · key_messages · summarize · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
disclaimer 1/1 image 1/1 list 3/3 title 2/2
Components 7
disclaimer illustration bullet bullet bullet action-title headline
Tools 2
2x2 matrix slide · 50%
The slide mentions a diagram of Dato-DXd antibody structure, which could be related to a 2x2 matrix, but there is not enough information to confirm.
AIDA Model slide · 50%The slide presents a product (Dato-DXd) and its features, which aligns with the AIDA model's attention and interest stages.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.